Intermediate density lipoprotein: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(One intermediate revision by the same user not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{High density lipoprotein}}
{{Intermediate density lipoprotein}}
{{CMG}}; {{AE}} {{AN}}; {{RT}}
{{CMG}}


== [[High density lipoprotein overview|Overview]] ==
== [[Intermediate density lipoprotein overview|Overview]] ==


== [[High density lipoprotein historical perspective|Historical Perspective]] ==
== [[Intermediate density lipoprotein historical perspective|Historical Perspective]] ==


== [[High density lipoprotein classification|Classification]] ==
== [[Intermediate density lipoprotein classification|Classification]] ==


== [[High density lipoprotein biochemistry|Biochemistry]] ==
== [[Intermediate density lipoprotein biochemistry|Biochemistry]] ==


== [[High density lipoprotein physiology|Physiology]] ==
== [[Intermediate density lipoprotein physiology|Physiology]] ==


== Clinical Correlation==
== Clinical Correlation==
===[[High HDL]]===
===[[High IDL]]===
[[High HDL epidemiology and demographics|Epidemiology and Demographics]] | [[High HDL pathophysiology|Pathophysiology]] | [[High HDL causes|Causes]] | [[High HDL diseases|Diseases]] | [[High HDL prognosis and complications|Prognosis and Complications]]
[[High IDL epidemiology and demographics|Epidemiology and Demographics]] | [[High IDL pathophysiology|Pathophysiology]] | [[High IDL causes|Causes]] | [[High IDL diseases|Diseases]] | [[High IDL prognosis and complications|Prognosis and Complications]]


===[[Low HDL]]===
===[[Low IDL]]===
[[Low HDL epidemiology and demographics|Epidemiology and Demographics]] | [[Low HDL pathophysiology|Pathophysiology]] | [[Low HDL causes|Causes]] | [[Low HDL diseases|Diseases]] | [[Low HDL prognosis and complications|Prognosis and Complications]]
[[Low IDL epidemiology and demographics|Epidemiology and Demographics]] | [[Low IDL pathophysiology|Pathophysiology]] | [[Low IDL causes|Causes]] | [[Low IDL diseases|Diseases]] | [[Low IDL prognosis and complications|Prognosis and Complications]]


== Treatment ==
== Treatment ==
[[High density lipoprotein medical therapy|Medical Therapy]] | [[High density lipoprotein primary prevention|Primary Prevention]] | [[High density lipoprotein secondary prevention|Secondary Prevention]] | [[High density lipoprotein landmark trials|Landmark Trials]] | [[High density lipoprotein future or investigational therapies|Future or Investigational Therapies]]
[[Intermediate density lipoprotein medical therapy|Medical Therapy]] | [[Intermediate density lipoprotein primary prevention|Primary Prevention]] | [[Intermediate density lipoprotein secondary prevention|Secondary Prevention]] | [[Intermediate density lipoprotein landmark trials|Landmark Trials]] | [[Intermediate density lipoprotein future or investigational therapies|Future or Investigational Therapies]]


{{Lipoproteins}}
{{Lipoproteins}}

Latest revision as of 17:10, 12 September 2013

Intermediate Density Lipoprotein Microchapters

Home

Patient information

Overview

Historical Perspective

Classification

Biochemistry

Physiology

Clinical Correlation

High IDL

Epidemiology and Demographics
Pathophysiology
Causes
Diseases
Prognosis and Complications

Low IDL

Epidemiology and Demographics
Pathophysiology
Causes
Diseases
Prognosis and Complications

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Landmark Trials

Future or Investigational Therapies

Case Studies

Case #1

Intermediate density lipoprotein On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Intermediate density lipoprotein

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Intermediate density lipoprotein

CDC on Intermediate density lipoprotein

Intermediate density lipoprotein in the news

Blogs on Intermediate density lipoprotein

Directions to Hospitals Treating Intermediate density lipoprotein

Risk calculators and risk factors for Intermediate density lipoprotein

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Historical Perspective

Classification

Biochemistry

Physiology

Clinical Correlation

High IDL

Epidemiology and Demographics | Pathophysiology | Causes | Diseases | Prognosis and Complications

Low IDL

Epidemiology and Demographics | Pathophysiology | Causes | Diseases | Prognosis and Complications

Treatment

Medical Therapy | Primary Prevention | Secondary Prevention | Landmark Trials | Future or Investigational Therapies

Template:WikiDoc Sources